Study shows the potential of Medicaid to improve cardiovascular health for specific subpopulations Cardiovascular disease is the leading cause of mortality globally, substantially impacting health and ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced detailed final overall survival (OS) results from CONTACT-02, a phase 3 pivotal study evaluating cabozantinib (CABOMETYX ...